Caption Management, LLC Seagen Inc. Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $10.4 Million - $11.4 Million	55,500 New	55,500 $10.7 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $3.84 Million - $5.11 Million	-28,389 Reduced 85.8%	4,700 $643,000
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $2.03 Million - $3.35 Million	18,679 Added 129.63%	33,089 $5.86 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $549,009 - $724,531	-4,590 Reduced 24.16%	14,410 $2.08 Million
Q4 2021 Feb 11, 2022	BUY	$142.57 - $190.86 $2.71 Million - $3.63 Million	18,999 Added 1899900.0%	19,000 $2.94 Million

Q3 2021 Nov 12, 2021	SELL	$142.45 - $169.82 $261,253 - $311,449	-1,834 Reduced 99.95%	1 $0
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $2.82 Million - $3.36 Million	-20,865 Reduced 91.92%	1,835 $290,000
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $3.12 Million - $4.33 Million	22,700 New	22,700 $3.15 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.